KRAS and colonic neoplasm: Most characteristics were similar between KRAS groups, although the MT KRAS PRO population included proportionally more women (20% vs. 46%), elderly patients (≥75 years of age; 7% vs. 19%) and patients with colon cancer (57% vs. 67%) compared with the WT population (Table1).